| ID | CAS | Name | Synonyms | Molecular Formula | Category |
|---|---|---|---|---|---|
| 1 | 155944-23-3 | ZM 230487 | ZM 230487 ICI230487 ICI 230487 ICI-230487 2(1H)-Quinolinone, 1-ethyl-6-[[3-fluoro-5-(tetrahydro-4-methoxy-2H-pyran-4-yl)phenoxy]methyl]- | ||
| 2 | 93957-54-1 | Fluvastatin | Lipaxan FLUVASTATIN Fluvastatin FLUVASTATIN NA FLUVASTATIN SODIUM FluvastatinC24H26FN04 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1h-indol-2-yl)-3,5-dihydroxy-6-heptenoic acid (6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate (3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid Methyl-(±)-(E)-7-[3'-(4'-fluoro-phenyl )-1'-(1'-methylethyl)indol-2'-yl]-3,5- dihydroxy-6- heptenoate FLUVASTATIN[METHYL-(±)-(E)-7-[3'-(4”-FLUOROPHENYL )-1'-(1”-METHYLETHYL)INDOL-2'-YL]-3,5- DIHYDROXY-6- HEPTENOATE ] | ||
| 3 | (3R,5S) Fluvastatin | (3R,5S) Fluvastatin (3R,5S)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic Aci | |||
| 4 | 2249799-34-4 | (3S,5R)-Fluvastatin D6 | 3S,5R-Fluvastatin D6 (3S,5R)-Fluvastatin D6 | ||
| 5 | 779995-42-5 | Fluvastatin EP Impurity C | Fluvastatin EP Impurity C | ||
| 6 | 93957-58-5 | Fluvastatin EP impurity A -G | Fluvastatin EP IMP A Fluvastatin Impurity A Fluvastatin Anti Isomer Fluvastatin EP impurity A Fluvastatin EP impurity A -G Fluvastatin EP Impurity A Sodium Salt | ||
| 7 | 155229-76-8 | (-)-3S,5R-FLUVASTATIN SODIUM SALT | (-)-3S,5R-FLUVASTATIN SODIUM SALT (-)-3S,5R-Fluvastatin-d6 sodiuM salt 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, (3S,5R,6E)- (3S,5R)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt | ||
| 8 | Fluvastatin for system suitability | Fluvastatin for system suitability Fluvastatin sodium - Fluvastatin sodium anti-isomer mixture | |||
| 9 | Fluvastatin Degradation Product (diastereomeric mixture) | Fluvastatin Degradation Product (diastereomeric mixture) | |||
| 10 | 1212316-84-1 | N-[2-(4-fluorophenyl)ethyl]-2-[(4-oxo-3,4-dihydrospiro[chromene-2,1'-cyclohexan]-7-yl)oxy]acetamide | N-[2-(4-fluorophenyl)ethyl]-2-[(4-oxo-3,4-dihydrospiro[chromene-2,1'-cyclohexan]-7-yl)oxy]acetamide Acetamide, N-[2-(4-fluorophenyl)ethyl]-2-[(4-oxospiro[2H-1-benzopyran-2,1'-cyclohexane]-7(3H)-yl)oxy]- | ||
| 11 | 174956-43-5 | 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, (3R,5R,6E)-rel- | 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, (3R,5R,6E)-rel- | ||
| 12 | Fluvastatin for System Suitability (25 mg) (Fluvastatin sodium and fluvastatin sodium anti-isomer ([R*,R*-E]-(+/-)-7-[3-(4-Fluorophenyl)-1-(methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt)) | Fluvastatin for System Suitability (25 mg) (Fluvastatin sodium and fluvastatin sodium anti-isomer ([R*,R*-E]-(+/-)-7-[3-(4-Fluorophenyl)-1-(methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt)) |
| ID | CAS | Product Name | Suppliers | Descriptions |
|---|